The Saint-Louis Research Center is also a dermatology research center in Quebec City. It plays a key role in medical innovation in dermatology by conducting rigorous clinical studies on various skin conditions such as eczema, psoriasis, atopic dermatitis, urticaria, lichen simplex and hidradenitis suppurativa. In collaboration with several well known dermatologists, mainly from the Saint-Louis Dermatology Clinic, these studies aim to develop new treatments and improve the management of patients with skin diseases.
Collaboration with the Saint-Louis Dermatology Clinic
The Saint-Louis Research Center works in close collaboration with the Saint-Louis Dermatology Clinic, a facility in the same building recognized for its dermatology expertise. This collaboration makes it possible to integrate their experienced dermatologists into the supervision of ongoing clinical studies. These specialists provide thorough follow up of participants, from the initial evaluation to the end of the trials, ensuring high standards of safety and treatment effectiveness. Thanks to this synergy, the studies conducted by this dermatology research center in Quebec City benefit from a structured clinical approach, offering participants the opportunity to access innovative therapies while contributing to the advancement of medical knowledge in dermatology.
Dermatology research center in Quebec City: dermatology clinical studies
Dermatology clinical trials help evaluate the effectiveness and safety of innovative treatments before they become available on the market. The Saint-Louis Research Center is a dermatology research center in Quebec City that conducts several studies on common and complex skin conditions, including:
Psoriasis: A chronic inflammatory disease requiring targeted therapeutic approaches to improve symptoms and patient quality of life.
Eczema: Studies are conducted to better understand the inflammatory mechanisms behind this condition and to develop new treatments for moderate to severe cases.
Acne and rosacea: These conditions, which affect a broad range of patients, are being studied to find more effective and better tolerated solutions.
Chronic urticaria: Trials aim to evaluate new molecules capable of reducing the frequency and intensity of flare-ups.
Vitiligo: Emerging treatments are being evaluated to promote repigmentation and slow disease progression.
Lichen simplex: A dermatological condition characterized by thickened, itchy patches often triggered by repeated scratching.
Hidradenitis suppurativa: A chronic inflammatory disease of the hair follicles that causes painful abscesses and scarring.
Each ongoing clinical study follows a strict protocol to ensure reliable results and complies with medical research standards and current regulations.
Participating in a dermatology clinical study
Participating in a clinical study allows eligible individuals to contribute to medical progress while receiving regular dermatology follow up. Participants may gain access to innovative treatment options, often not yet available on the market, and receive care from a qualified medical team for a specific dermatological condition.
The Saint-Louis Research Center regularly recruits participants for its ongoing dermatology studies. Those interested can consult the list of dermatology clinical studies in Quebec City and check their eligibility by contacting the research team.